ProLung, Inc. presents highest combined sensitivity and specificity values for a truly non-invasive lung cancer solution pursuing FDA clearance at ISRD & ATS joint medical conference
In News
ProLung, Inc. presents highest combined sensitivity and specificity values for a truly non-invasive lung cancer...
Read More